s6y
Company name or ticker
Search
Can-Fite BioPharma Ltd.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Friday, January 14, 2022
Accession number
0001213900-22-002156
Documents
PROSPECTUS SUPPLEMENT
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header